Page 20«..10..19202122..3040..»

PMR Sales Revenue in the Induced Pluripotent Stem Cells Market to Witness Growth at Robust CAGR 7% During 2026 – Cole of Duty

By daniellenierenberg

The healthcare industry has been focusing on excessive research and development in the last couple of decades to ensure that the need to address issues related to the availability of drugs and treatments for certain chronic diseases is effectively met. Healthcare researchers and scientists at the Li Ka Shing Faculty of Medicine of the Hong Kong University have successfully demonstrated the utilization of human induced pluripotent stem cells or hiPSCs from the skin cells of the patient for testing therapeutic drugs.

The success of this research suggests that scientists have crossed one more hurdle towards using stem cells in precision medicine for the treatment of patients suffering from sporadic hereditary diseases. iPSCs are the new generation approach towards the prevention and treatment of diseases that takes into account patients on an individual basis considering their genetic makeup, lifestyle, and environment. Along with the capacity to transform into different body cell types and same genetic composition of the donors, hiPSCs have surfaced as a promising cell source to screen and test drugs.

Report Highlights:

Get Sample Copy of Report @https://www.persistencemarketresearch.com/samples/17968

Company Profile

Get To Know Methodology of Report @https://www.persistencemarketresearch.com/methodology/17968

In the present research, hiPSC was synthesized from patients suffering from a rare form of hereditary cardiomyopathy owing to the mutations in Lamin A/C related cardiomyopathy in their distinct families. The affected individuals suffer from sudden death, stroke, and heart failure at a very young age. As on date, there is no exact treatment available for this condition.

This team in Hong Kong tested a drug named PTC124 to suppress specific genetic mutations in other genetic diseases into the iPSC transformed heart muscle cells. While this technology is being considered as a breakthrough in clinical stem cell research, the team at Hong Kong University is collaborating with drug companies regarding its clinical application.

The unique properties of iPS cells provides extensive potential to several biopharmaceutical applications. iPSCs are also used in toxicology testing, high throughput, disease modeling, and target identification. This type of stem cell has the potential to transform drug discovery by offering physiologically relevant cells for tool discovery, compound identification, and target validation.

A new report by Persistence Market Research (PMR) states that the globalinduced pluripotent stem or iPS cell marketis expected to witness a strongCAGR of 7.0%from 2018 to 2026. In 2017, the market was worthUS$ 1,254.0 Mnand is expected to reachUS$ 2,299.5 Mnby the end of the forecast period in 2026.

Access Full Report @https://www.persistencemarketresearch.com/checkout/17968

Customization to be the Key Focus of Market Players

Due to the evolving needs of the research community, the demand for specialized cell lines have increased to a certain point where most vendors offering these products cannot depend solely on sales from catalog products. The quality of the products and lead time can determine the choices while requesting custom solutions at the same time. Companies usually focus on establishing a strong distribution network for enabling products to reach customers from the manufacturing units in a short time period.

Entry of Multiple Small Players to be Witnessed in the Coming Years

Several leading players have their presence in the global market; however, many specialized products and services are provided by small and regional vendors. By targeting their marketing strategies towards research institutes and small biotechnology companies, these new players have swiftly established their presence in the market.

View original post here:
PMR Sales Revenue in the Induced Pluripotent Stem Cells Market to Witness Growth at Robust CAGR 7% During 2026 - Cole of Duty

To Read More: PMR Sales Revenue in the Induced Pluripotent Stem Cells Market to Witness Growth at Robust CAGR 7% During 2026 – Cole of Duty
categoriaSkin Stem Cells commentoComments Off on PMR Sales Revenue in the Induced Pluripotent Stem Cells Market to Witness Growth at Robust CAGR 7% During 2026 – Cole of Duty | dataMay 11th, 2020
Read All

Art in the waiting room – The Spinoff

By daniellenierenberg

Megan Dunn takes a long look at the art in the Auckland Hospital collection and finds out that yes, there is art, even in intensive care but the price of seeing it is everything.

I got the pamphlet in the mail back in January. It says after someone close to you dies it is natural to:

The day the pamphlet arrived I splayed it open and looked at the photo inside: a network of hands holding other hands. Cropped close. Just linked hands held in support of one another. Beneath the photo: we grieve as deeply as we love.

I am unable to return to normal services.

Painting from collection donated by the Art Komiti of Aucklands Paremoremo Prison

I had noticed art in waiting rooms before, not art with a capital A, not the kind of art that an art writer such as myself would bother to write about, because art like so much else in our society has its hierarchy. Contemporary art is a high-stakes game; who you write about is as important as what you say. Who cares about the art in the waiting room? Lets abbreviate: who cares?

Me. Ive had cause to think about it because last year Mums cancer returned from outer space. Shed been in remission for 17 years, which might be a national record for multiple myeloma, a cancer of the blood. Ive never really understood what her cancer is, just that she beat it first time round, and, last July, the cancer cell count was up. Then she started chemo.

Im not coping, Im just not coping, Mum called after the first round, in tears.

Have you eaten anything?

No. I dont feel like eating.

It was the dex. The specialist, a blonde in a miniskirt and long black boots, said, Thatll be the dex. Short for dexamethasone, a steroid. Another bitter pill to swallow. At that point Mum had to take up to 10 pills a day. I looked at the specialist. I was angry. Mums not coping. I had flown to Auckland to join Mum for her next haematology appointment.

But what art could I prescribe? Optimism matters, but art isnt always soothing or kind.

Im lucky I have a chance of getting better, Mum said. True. Her prognosis was good.

We went upstairs for her second round of chemo. The nurse in blue gown, gloves and a shower cap wheeled it around in a mauve container, hooked it on a drip, and inserted the port into Mums vein.

Other patients stretched out on beds like La-Z-Boys, skin drained. They too were waiting, but looked like they didnt have a chance of getting better.

I stared into the little office next to Mums chair. Harried papers on the desk; a PC lit up like a bright face, ready to supply details, cheer, whatever counts most. On the wall, an original painting of a phutukawa tree. I call it original but the concept wasnt. The sea peeked out of the background, the sky bluer than the sea. The oils had been used with little mixing, but I didnt mind that painting of the beach in summer rudely lit up by the phutukawa tree, the needles burst open in the leaves, red as fireworks.

The nurses are very nice here, Mum said.

Niceness counts like stem cells it has a tally.

That was quick, I said.

It really doesnt take long.

I wondered how long the painting took the artist. Guessing from the paint application, not long, but longer than it takes a dose of chemo to run into your veins.

I wanted to ask the nurse: who bought that painting? Who is the artist? Who put that there? But I was too shy. Why stop this real raw moment, for an intellectual aside, a detour into the art we look at it when were waiting to get better or to see how much worse it can get?

The painting of the phutukawa tree in summer yields its bouquet. Just be.

***

Mum and I got lost en route to blood work. The hospital has an art collection in its corridors that must be maintained by someone, however irregularly. We passed a Claudia Pond Eyley print black lines of plants, bright colours, a Pacific infusion abandoned along a corridor. A trio of photographs of flowers. Where are we? Is it this the way? They need to give better directions. Then, in a gangway, a pair of large, textured, brown abstracts, neither good nor bad, just out of time, like photos of your parents when they were young, in the fashions of the day. Those sideburns. What chops! Mums perm. Dads flares. A big Pat Hanly painting called Vacation was by the escalator. I meant to come back, retrace my steps, and find all this art again. And I did come back, but by then everything had changed.

I dont want to write what comes next, because I dont want the wait to be over. Waiting is a comfort in its own sad way. Just wait and see.

The sea. Waves lap in and out. I see it whenever I attend my doctors surgery above Courtenay Place. Piha is by the Korean-born photographer Jae Hoon Lee. Its moved around the surgery over the years. Now its in the waiting room above a line of plastic chairs. Whoever bought it must have thought it was soothing and anaesthetic, a balm for a worried soul like mine.

What do you want to see when you go for a smear test, or hold a baby that wont go the fuck to sleep, or wait with your partner for test results, a prognosis, a new vaccine?

I thought Ill wait to write about the art at the doctors surgery or the hospital. Or the dentist, though I have not been to the dentist in ages, no cash, so Ill wait. How much art is in your life? How many fillings? Do you have art at home? If so, what? Where did you get it? At what price?

In the waiting room, I dont blame you if you dont want to look at something difficult and ugly or think about something hard. If youre just after a good view, Arent we all?

At my doctors surgery Pihahangs near a plastic container for pamphlets, ruffled in waves.

For every problem there is a pamphlet.

The pamphlet that arrived in the mail in January is titled Department of Critical Care Medicine Bereavement Follow-up Service.

Piha in situ at Courtenay Medical, Wellington

The waiting room isnt just literal, but it is literal too. I know because the last time I was there I got a hot chocolate from the machine. Warm, syrupy. No art, just a TV on the wall.

At the haematology department, I watched a dad sitting with his young daughter on his lap. Her mind looked far away. She waited with the patience of one who has waited before. Then her mum appeared in a turban. I looked at this young mother, I had no idea what cancer of the blood she had, but I really hoped she had a chance of getting better.

Two in 100 people die, Mum said. Back in December she was waiting for her stem-cell transplant. She would be in hospital for two to three weeks. The transplant would take her immunity to zero that was where the risk of infection crept in but then the white cells would ingraft and her count would go back up. Shed signed the forms, accepting the 2% chance she would die. If theres not a bed on Thursday, it will be next week.

I wondered: Will there be any art in her room? And if so, what will it say?

The phutukawa painting in the office of the haematology department says shush shush, that lulling noise of waves from the beach. Dont worry, relax. Its OK. Look at the view. But the Jae Hoon Lee photograph in my doctors surgery says to me your hurt is timeless, the sea will exist whether we do or not, release your grip, whatever happens next will be surgically safe, emotions are never still, time is an inlet, the sea runs in and out.

***

I always knew that waiting was part of the problem. What if you wait too long? Then you cant get around to what you were going to say because you are:

***

Outside Ward 82, ICU (acute surgery). On the intercom, the number one has been buzzed off, pushed too many times. All other numbers present and correct. My mother is in bed 17, I tell the intercom, after Ive pressed the number one that isnt there and waited. Then I walked through vaguely yellow corridors lined with three framed prints, each composition a rectangle yellow, blue, orange lined with holes down the middle. They reminded me of paeans to the common household sponge. I stop at the hand-gel pump and sanitised. The art at the hospital is sanitised too but Im beyond caring. Too much caring and you move though it and pass out on the other side somewhere in the vicinity of bed 17.

At the end of the corridor past the hand gel, the Chen family have donated a small square print, red with black scribble, in honour of the ICU team. I clocked the gold engraved plaque, their appreciation registered on the wall. The painting not unlike the size of a fire alarm, but there is no glass to break open, the call has already been raised.

I got the call from the registrar on December 22 to say that Mums stem-cell plant was not going as expected and she had been admitted to ICU.

Ive been thinking about what I will do when I get better, Mum said, the night I arrived. She sat propped up in bed, on oxygen. Her face flushed, swollen, but superficially OK.

I sat next to her bed. Oh yes, what do you think?

Im going to come to your book launch.

I smiled. My book of personal essays about art and life, already way behind schedule.

What else? I asked.

I might meet someone new. I might travel.

Where would you like to go? I asked.

She paused. Maybe Africa, she said. I could go on a safari.

I nodded. Mum found it hard to walk up the small pronounced hill to our house in Wellington, sweated easily, mopped her forehead. Then shed wait, slightly panting, for her breath to right itself again, restart.

That night, I slept in the hospital. They say you can stay in my room at the Motutapu Ward, Mum said. There was no art in her room, but a wall-to-ceiling poster of a forest, kauri trees, dense, shady, green.

In the morning I got buzzed back into ICU. Mums arms and legs, twitched, calling out; face red, body puffed up; trying to unpick the PICC line from her arm, in among the beeping and the rising heart monitor, the oxygen exhaling. She doesnt recognise me, is raving to the charge nurse, who held her hand and looked at me and explained, Im just going some gentle reorientation work.

I must have seemed stunned.

Do you want to speak outside the room? the charge nurse asked.

I nodded. In the room next door to bed 17, I wailed, What is happening? Oh, what is happening? The charge nurse held me in place and comforted me, when there was no comfort to give.

Next the intensivist arrived in her blue scrubs, removed her surgical mask, wiped her hands with gel, introduced herself as Kylie. She wanted a family meeting.

The whnau room: the painting was donated by the Art Komiti of Aucklands Paremoremo Prison

The whnau room at ICU contains another Claudia Pond Eyley print on one wall and a multi-panel painting of a New Zealand landscape on the other. The mountains, a lake, smooth and even and still. A perennial view of nature, so calm, so undisturbing to see. I cant blame the hospital for containing so many paintings of the view sky, sand, sea, soothing, stretching, somehow infinite. A vista of comfort, comprehended.

I sat down on one side of the big meeting table, Kylie on the other. What is your understanding of your mothers condition? she asked. I rattled off the facts while an accompanying nurse took notes.

Mum had come in for a stem-cell transplant. She had caught pneumonia at a point in the process when she had no natural immunity. She had developed delirium. Her pre-existing heart condition had been set off: arterial fibrillation. She needed oxygen support to breathe.

This is what the 2% of risk looks like? I asked.

Yes. Kylie explained that they couldnt provide sedatives like morphine as that would risk compromising Mums breathing further. They could put Mum on a ventilator if she deteriorated but that would not be a good sign and would come with an extra level of risk. What helped patients with delirium was familiar voices.

I asked her, Are you holding anything back?

Just that this is very life threatening. Her eyes, an expression, I can now only call grave.

Well, it seemed apt. I liked Kylie. The intensivist understood how much intensity was required.

The job title intensivist seemed funny to me because in high school I was always told I was too intense. We have to find a happy medium, a teenage girlfriend once told me. So I got into art because it seemed like a place where intensity went and didnt have to turn down a notch. But art isnt the only place for intensity. At the intensive care unit (acute) on the eighth floor of Auckland Hospital the intensivists are also at work.

All day the nurse at bed 17 and I spooned jelly or orange juice into her mouth, helped her not frantically unpick her PICC line, I just want to go for a walk! No, no dear, you cant get up. Mum, you just need to rest. Rest. A familiar voice on replay. Youll feel so much better if you rest.

In the night I noticed the print of a lone bugle boy down some New Orleans alley, presumably playing jazz. No plaque. Who bought it? What family? Who was lost?

In ICU the beeping was persistent, insistent. The constant sound of inhaling, exhaling. Poke your tongue out. Ahhhh. Good girl.

Were concerned about the delirium. In ICU, delirium can be intensified, especially in older people, by the strange sounds, lights, faces.

I forgot the ducks! I keep meaning to mention the duck painting, a watercolour, a good one too, of some ducks paddling around their pond, giving no quacks in ICU. The duck pond was donated by another family, with a brass plaque. I should have jotted down the name.

The eyeball is so moveable, up and over, it can even see things that arent there. Mum said her family prayer, over and over, eyes roving. We consecrate to Thee, O Jesus of Love My aunt clutched her hands and said the prayer with her.

One night in ICU I passed a large rectangular collage of brightly coloured red and pink buttons like some budget Damien Hirst pill painting. Never passed it again. Beep, beep.

Her oxygen levels are saturating nicely.

How much?

Fifty-five percent, then down to 48%.

Dont obsess about the blood count.

Look at the patient. Look at the face.

The face her not her.

My daughter in the car on the way to the hospital singing: Pop bang crack goes the Christmas cracker, pop bang, crack goes the Christmas cracker, we will pull it off POP.

Eyes popped, snapped.

Shes been restless.

You need to sleep.

Sleep.

I stop and start, keep typing the next line, then deleting it. I dont want to get to the end of this. I dont want to remember all the family meetings in the whnau room waiting. I dont want to chart the order of those disordered days.

What was I going to say about art?

***

I spent the first weekend after Mums stem-cell transplant in her room at the Motutapu Ward. Motutapu means sacred or sanctuary. Shed just had the big dose of chemo and was quiet, but not yet unwell. My aunt was going to join her on Monday Mums 69th birthday for what would be the worst week of the process. I sat on the bed, Mum on the La-Z-Boy. We said not a whole lot.

At one point, I think I can manage a walk.

We passed the two nurses stations. En route I pointed out the art. We stopped by a faded print of sunflowers, beneath glass, but the artist was no Van Gogh. The first time Id passed the sunflowers, I hadnt rated them at all. But that was before Id read that they were by Chris Corlett, a 17-year-old who died of acute lymphoblastic leukaemia 20 years ago. Sunflowers of Hope does look like it was painted by a teenage boy. Theres something gnarly about them. Large and abundant. Full of life. Except for the leaves Chris paid special attention to the leaves stippled with decay, a bit heavy metal.

Sunflowers of Hope, Chris Cortlett, Auckland Hospital, 2019.

We stood reading the accompanying framed text about the foundation Chris had started to build up a database of 100,000 bone-marrow donors.

Courage, charisma, strength of character, sincerity whatever it is that makes some people inspirational and very special, Chris Corlett had it.

Another Claudia Pond Eyley print near the kitchen and on the door a sign that read: Dont use if youre come from a red room. I was confused by it when Id made Mum a cup of tea earlier and had to ask the nurse, Is this a red room? (Mums room was not a red room.)

I felt the light weight of Mums hand on my arm as we looped around to reception. I showed her my favourite painting, tucked in a corner. Its colours were so bold that from the corner of my eye I first suspected Matisse. Then was embarrassed when I realised the artist is Harriet, aged six, who donated Flowers for the Leukaemia Ward in memory of her father, Ned.

Harriet may not be Matisse but for a six-year-old her vase of flowers is a masterpiece of colour and compression.

More:
Art in the waiting room - The Spinoff

To Read More: Art in the waiting room – The Spinoff
categoriaSkin Stem Cells commentoComments Off on Art in the waiting room – The Spinoff | dataMay 10th, 2020
Read All

World Thalassemia Day 2020: Causes, Symptoms, Diagnosis And Treatment of The Disease – India.com

By daniellenierenberg

World Thalassemia Day is an annual observance day that occurs on May 8th. It is a world-wide campaign to raise awareness about thalassemia and its symptoms. This is done to help the patients living with this genetic disorder. World Thalassemia Day commemorates thalassemia victims and also aims at making thalassemia patients aware about the significance of medical consultation before marriage. This global observance day also tries to debunk myths and misconceptions surrounding the disease. The theme of World Thalassemia Day 2020 is Begin thalassemia prevention from young age, blood test before marriage will make the future generation safe. On this day, here we tell you all about the disease. Also Read - World Thalassemia Day 2019: How to Deal With Thalassemia

It is a genetic blood disorder that significantly reduces your haemoglobin count. Notably, haemoglobin is a protein molecule present in red blood cells. This protein helps RBCs in carrying oxygen and circulating it in the entire body. Also Read - World Thalassemia Day: Risk Factors, Types And Prevention Tips

The signs and symptoms of thalassemia depend on the type of thalassemia you have and its severity. Some common symptoms include fatigue, slow growth, weakness, abdominal swelling, pale skin, dark urine facial bone deformities etc. Usually, either a newborn shows thalassemia symptoms at the time of birth itself or develops it in the first two years of life. Also Read - World Thalassemia Day 2017: Importance of Blood donation and how it helps people with this fatal disease

Thalassemia occurs when the DNA of your body cells responsible for making haemoglobin, undergo mutation. This mutated DNA is passed on to the next generation.

A simple blood test can confirm the disease. Usually, if an expecting mother is known to be suffering from thalassemia, doctors perform a certain tests to find out if the fetus has also inherited the diseases and if yes, what is the severity of the genetic disease. To do that, chorionic villus sampling (testing a tiny sample of placenta) and amniocentesis (examining sample of fluid surrounding foetus) are performed.

In case, you have inherited a minimum number of mutated genes and suffering from mild thalassemia, you do not require treatment. However, in severe case, you may have to go through frequent blood transfusion, chelation therapy, or stem cell transplant.

Read more from the original source:
World Thalassemia Day 2020: Causes, Symptoms, Diagnosis And Treatment of The Disease - India.com

To Read More: World Thalassemia Day 2020: Causes, Symptoms, Diagnosis And Treatment of The Disease – India.com
categoriaSkin Stem Cells commentoComments Off on World Thalassemia Day 2020: Causes, Symptoms, Diagnosis And Treatment of The Disease – India.com | dataMay 9th, 2020
Read All

11 Skincare Products To Try Now Injectables Are Off The Cards – British Vogue

By daniellenierenberg

Youve probably seen those before-and-after quarantine memes, the ones featuring faces or more specifically, lips that have undergone a drastic change in shape in the absence of access to an aesthetician. Exaggerated they might be, but it is true that lockdown has left an injectable-shaped hole in some of our lives, and whether youre into them or not, our newly facial-free (and less-than-active) lifestyles are wreaking a certain amount of havoc on our skin anyway. For those who have regular in-clinic treatments, lockdown can mean that lines start to show, full lips diminish, cheeks depress and sunken eye sockets and dark circles re-appear, says aesthetic doctor Dr Sophie Shotter, who has temporarily shuttered her clinic and returned to the NHS frontline to join the fight against Covid-19. And, while the issue might seem trivial in light of everything else going on in the world, it is possible to harness the power of intelligent skincare to help mimic the effects of filler and Botox in lieu of the real thing. Dr Shotter shares her tips here.

Filler is routinely administered to add volume to the skin, usually in the face, says Shotter, who explains that its made from hyaluronic acid, a molecule we should all be utilising in our skincare routines to help soften fine lines. One of the best serums for the job is SkinCeuticals HA Intensifier, which boosts hyaluronic acid levels in the skin, making it look and feel firm, plump and hydrated. Alternatively, try LOrals Revitalift Filler Hyaluronic Acid for a more affordable option.

To smooth skin, Shotter also recommends BioEffect EGF Serum, which boosts skin thickness and collagen levels in the skin, meaning fewer wrinkles and a healthy glow. And finally, look to SkinBetter Science AlphaRet Overnight Cream to reap the benefits of prescription strength vitamin A (otherwise known as retinol): Retinol is the ultimate age management molecule that increases collagen levels, she says.

If youve had Botox before, you will know that its a toxin injected where there are dynamic lines to relax them and remove creases within the skin, says Shotter. There are products that mimic its effects: Meder Skincare Myo-Fix Concentrate, is full of muscle-relaxing peptides that work to block the nerve communicating with the muscle. Although it might sound daunting, its totally safe to use, and Shotter recommends regular and sustained use for the best results. Another great product to use if you usually have Botox administered superficially to regulate oil production is Institut Esthederms Pure System Pore Refiner Concentrate it is silicone based so refines their appearance beautifully.

Used religiously, there are products that can help to lift and plump the lips, although, like all of the products listed here, they wont have effects on a par with the treatment itself. One of the best to try is Fillerinas Lip Volume Grade 3, which contains six different hyaluronic acid molecules of varying weights and sizes, to deeply hydrate lips and give a fuller effect with continual use. Shotter also recommends a brilliant lip balm. Medik8s Mutiny Squalane Lip Balm helps to nourish and heal the lips, drawing moisture to the area to give them a plumper, more hydrated look, she says, adding that its important to use SPF to protect them from collagen-depleting UV rays. Protecting the health of the lips will help them stay plump and full.

Filler is often strategically placed to fill the hollows under the eyes, to refresh and hydrate and to lift dark circles, says Shotter. A (plant-based) stem cell serum, like Dr Levy Intense Stem Cell Eye Booster Concentrate, will boost the thickness of the delicate under eye skin, plus it also contains retinol and antioxidants to smooth fine lines and brighten the area. MGC Dermas CBD Stem Cells and Peptides Eye Cream is a brilliant option too, thanks to firming peptides, hyaluronic acid and calming CBD.

More from British Vogue:

Continue reading here:
11 Skincare Products To Try Now Injectables Are Off The Cards - British Vogue

To Read More: 11 Skincare Products To Try Now Injectables Are Off The Cards – British Vogue
categoriaSkin Stem Cells commentoComments Off on 11 Skincare Products To Try Now Injectables Are Off The Cards – British Vogue | dataMay 7th, 2020
Read All

FDA Approves Tabrecta, the First Targeted Drug for Patients with Non-Small Cell Lung Cancer and MET exon 14 – Curetoday.com

By daniellenierenberg

Tabrecta (capmatinib) will treat patients with metastatic non-small cell lung cancer that has a mutation leading to MET exon 14 skipping. The drug is the first targeted option for patients with lung cancer and this type of mutation.

Tabrecta is the first therapy approved by the FDA specifically to treat NSCLC with mutations that lead to epithelial-mesenchymal transition (EMT), which is MET exon 14 skipping.

Tabrecta is approved for patients who are new to treatment and also those who have received previous therapies, regardless of prior treatment type.

Along with the drug approval, the FDA gave the green light to a companion diagnostic, the FoundationOne CDx assay, which can identify these mutations in patients.

In epithelialmesenchymal transition(EMT), the cells that line an organ lose their polarity and ability to adhere to other cells, giving them the ability to invade tissues and organs. MET exon 14 skipping means that a segment of RNA that should prompt the production of a specific protein stops sending those messages.

The spread of cancer consists of a sequential series of events and MET exon 14 skipping is recognized as a critical event in this process, the FDA stated in a press release about the approval. Mutations leading to MET exon 14 skipping are found in 3% to 4% of patients with lung cancer, the agency stated.

Lung cancer is increasingly being divided into multiple subsets of molecularly defined populations with drugs being developed to target these specific groups, said Dr. Richard Pazdur, director of the FDAs Oncology Center of Excellence and acting director of the Office of Oncologic Diseases in the FDAs Center for Drug Evaluation and Research, in the release.

Taken orally, Tabrecta works by blocking a key protein that drives metastatic NSCLC in these patients. The FDA approved it based on the results of a clinical trial involving patients with NSCLC who had mutations leading to MET exon 14 skipping; their tumors did not express the proteins EGFR or ALK.

The evaluated study population included 28 patients who had never undergone treatment for NSCLC and 69 previously treated patients. The overall response rate (ORR; the percentage of participants who experienced a prespecified amount of tumor shrinkage) for the 28 participants was 68%, with 4% having a complete response and 64% having a partial response.

The ORR for the 69 participants was 41%, with all having a partial response. Of the responding participants who had never undergone treatment for NSCLC, 47% had a duration of response lasting 12 months or longer compared with 32.1% of the responding participants who had been previously treated.

Common side effects for patients taking Tabrecta included swelling of the legs, nausea, fatigue, vomiting, shortness of breath and decreased appetite.

Tabrecta may cause serious side effects including scarring or inflammation of the lungs. It may also cause damage to liver cells or harm a developing fetus or newborn baby. Patients may be more sensitive to sunlight when they take Tabrecta and should take precautions to cover their skin and use sunscreen.

Tabrecta was approved under theFDAs accelerated approval, breakthrough designation and priority review programs, which provide for a quicker review of drugs that treat serious or life-threatening diseases and represent a meaningful advantage over existing treatments.

Continued approval for this indication may be contingent upon verification of these results in confirmatory clinical trials.

Check back for what you need to know regarding this approval.

More here:
FDA Approves Tabrecta, the First Targeted Drug for Patients with Non-Small Cell Lung Cancer and MET exon 14 - Curetoday.com

To Read More: FDA Approves Tabrecta, the First Targeted Drug for Patients with Non-Small Cell Lung Cancer and MET exon 14 – Curetoday.com
categoriaSkin Stem Cells commentoComments Off on FDA Approves Tabrecta, the First Targeted Drug for Patients with Non-Small Cell Lung Cancer and MET exon 14 – Curetoday.com | dataMay 7th, 2020
Read All

Anglo African Oil & Gas mystified by sharp share price hike – Proactive Investors UK

By daniellenierenberg

Verditek PLC (LON:VDTK), the cleantech play, tumbled 11% to 2.85p after it announced a share subscription to raise 1mln.

The company issued 40mln shares at 2.5p a pop.

The newly-issued shares represent about 14% of the company's enlarged issued share capital.

KRM22 PLC (LON:KRM) plunged 44% to 23.5p after it said it is continuing talks about potential fundraising.

The risk management software specialist put out a statement on Thursday afternoon in response to a fall in its share price.

Discussions with shareholders and certain other investors regarding an equity fundraising or potential alternative financing are continuing, the London-based company said.

Anglo African Oil & Gas PLC (LON:AAOG) shares were up 21% at 0.85p, much to the mystification of the companys management.

The shares started the week at 0.22p and closed last night at 0.7p, prompting the company to issue a statement that essentially said: dont ask me, guv.

On 1 May the company completed the sale of Anglo African Oil & Gas Congo to Zenith Energy Limited on the terms set out in the announcement of 17 April 2020.

AA PLC (LON:AA. shares rallied 13% to 29.8p as its financial results highlighted a resilient, cash generative business, albeit the financials cover the pre-coronavirus period.

The roaside recovery firm's revenue for the twelve months ended 31 January 2020 amounted to 995mln, up 2%, while operating profit increased 17% to 257mln.

Profit before tax rose by 102% to 107mln, with earnings per share at 14.1p from 6.9p in the preceding year.

Crimson Tide PLC (LON:TIDE), the software company, rose 21% to 2.6p after it reported a sharp rise in pre-tax profits for 2019.

The company behind the Mpro5 mobile workforce management app saw profit before tax soar to 352,000 from 69,000 in 2018.

The company said the profit increase was achieved despite a strategy of significant increase in sales and marketing expenditure.

Filta Group Holdings PLC (LON:FLTA) soared 76% to 126p in early trade on Thursday after it launched a new sanitising service to help businesses prevent the spread of coronavirus (COVID-19).

The provider of fryer management and other services to commercial kitchens has launched FiltaShield, which is an anti-viral product developed for use in restaurants, bars, shops and offices (those that are still open) as well as healthcare facilities.

The solution is applied to a surface by spraying or fogging, leaving behind a mono-molecular layer that bonds to the surface and protects surfaces for up to 30 days.

Not just for kitchens, perfect for any public space. Hit me up for the deets #ROC. #FiltaShield #Sanitize #StopTheSpread https://t.co/0KCiqrwV2i

Best of the Best PLC (LON:BOTB) rose 18% to 512.5p as it raised full-year revenue and profit guidance.

The competitions runners switch to an online model it used to waylay travellers at airports to try to persuade them to enter a competition to win a car (tricky as a car would have been hard to fit in the suitcase) looks to have paid off.

The company said the second half of its fiscal year, which runs to the end of April, was particularly strong.

88 Energy Ltd (LON:88E) (ASX:88E) said it has reached an agreement with XCD Energy Ltds (LON:ASX:XCD) board for a unanimously recommended merger. The prior unsolicited takeover bid had achieved backing of about 18.5% of XCDs shareholders, and the recommended merger comes with improved terms. In the all-paper deal, 88 Energy will issue 2.4 new 88 Energy shares and 0.7 for every listed share option held -up from 1.67 per share and 0.5 per option. XCDs board now recommend that its shareholders accept the offer, in the absence of any superior proposals. They will hold around 20% of the enlarged company as a result of the transaction.

C4X Discovery Holdings PLC (LON:C4XD), the AIM-listed drug discovery company, has announced plans to raise at least 1mln by placing shares at 15p a throw. C4X shares closed at 15.25p yesterday. The net proceeds from the placing will be used to further strengthen the companys balance sheet as its partnering and strategic collaborations progressand will boost working capital during the progression of its pipeline portfolio.

MaxCyte Inc (LON:MXCT) has signed a clinical and commercial agreement with a US life sciences group for its cutting edge gene-editing technology. Caribou Biosciences will use MaxCytes flow electroporation systems and the companys ExPERT platform in its allogeneic t-cell therapy programmes. MaxCyte will receive undisclosed development and approval milestones as well as sales-based payments and other licensing fees. This important agreement represents another key expansion for MaxCyte, emphasising the value of our technology platform to companies developing pioneering gene-editing and cell therapies, MaxCytes chief executive, Doug Doerfler said in a statement.

Panther Metals PLC (LON:PALM) has announced the commencement of a three-week field exploration programme from this weekend on the gold-focused Big Bear property in Ontario, Canada. The main market-listed company, which is focused on mineral exploration in Canada and Australia, said the three-week work sampling and mapping programme, which will build its understanding of possible drill and trench targets is commencing on May 10. It noted that the work will target both orogenic gold and volcanogenic massive sulphide (VMS) style mineralisation.

ReNeuron Group PLC (LON:RENE) said new positive data relating to its CTX cell therapy candidate have been published in the peer-reviewed scientific journal Stem Cells. The developer of cell-based therapeutics said the data was included in a paper entitled "Implantation of the clinical-grade human neural stem cell line, CTX0E03, rescues the behavioural and pathological deficits in the quinolinic acid-lesioned rodent model of Huntington's disease". It said the new data show for the first time that ReNeuron's CTX human neural stem cell line can rescue deficits associated with an accepted animal model of Huntington's disease, a progressive genetic brain disorder.

NQ Minerals PLC (LON:NQMI) has unveiled a new resource statement for the Beaconsfield gold mine in Tasmania. Total resources rise to 1.454mln tonnes at a grade of 10.3 grams per tonnes (g/t), for 483,000 ounces gold. There are 354,000 ounces in measured and inferred resources, 485,000 tonnes at 11.4 g/t in measured for 177,000 ounces and 492,000 tonnes at 11.2 g/t in indicated for 177,000 ounces. A further 477,000 tonnes at 8.4 g/t remain in the inferred resource category, and, the company told investors that significant additional gold potential is still to be assessed.

Next Fifteen Communications Group PLC (LON:NFC) has announced that Penny will become the new chair of its board with effect from February 1, 2021, replacing Richard Eyre who will complete nine years as its chairman on May 11, 2020. Ladkin-Brand, who has chaired the Next 15 Audit Committee since 2017, also becomes the companys Senior Independent Director with immediate effect. The group said its board has asked Eyre to continue in the post to the end of the current financial year, and, consequently, he will seek re-election at the AGM and be available to support a smooth transition. Ladkin-Brand is currently chief financial officer at Future PLC (LON:FUTR), the FTSE 250 global multi-platform media company, and she will be moving into a new role of chief strategy officer on June 1, 2020, and will step down from the groups board.

Frontier IP Group PLC (LON:FIPP) said its portfolio firm Exscientia has entered into a collaboration with US research centre SRI International to expedite the discovery of molecules for a high-value oncology target. The IP investor said the agreement will see the two firms implement a new approach to drug discovery using SRIs automated synthetic-chemistry system with Exscientia's Centaur Chemist system. Frontier IP owns a 2.3% stake in Exscientia.

Eden ResearchPLC (LON:EDEN) said it is poised to capitalise on new product and market opportunities in 2020 as it predicted more sales for its Cedroz product. Posting its results for the year endedDecember 31, 2019, the biopesticide specialist said it expected to build on the sales achieved in the territories where it received approvals during 2019 and early 2020, including sales for Cedroz in Spain, Italy, France, Belgium, the Netherlands and the United Kingdom where the applications for registrations have now been outstanding from the early part of 2019. The firm also said it expected US regulators to approve Cedroz and its Mevalone product during 2020, although the pace of approvals hasbeen slowed by the coronavirus (COVID-19) pandemic.

Premier African Minerals Ltd (LON:PREM) has agreed to acquirea further 7% interest in the Otjozondu manganese mining project in Namibia. The transaction sees Premier buy a 7% interest in MN Holdings Limited, the projects owner, for US$700,000 paid in new shares. It will increase Premier Africans stake in MN to 19%. This further proposed increase in our holding in MNH is based on the same valuation formula applied to our initial acquisition, George Roach, Premier African's chief executive said in a statement released after the market close on Wednesday.

Amryt Pharma PLC (LON:AMYT) has taken another important step towards the global launch of its phase III treatment for the rare skin condition epidermolysis bullosa (EB) by announcing its brand name. AP101 will be launched commercially as FILSUVEZ. This, alongside our recent completion of recruitment into the EASE study, represents further progress as we endeavour to develop a therapy for patients with EB, a rare and distressing genetic skin disorder affecting young children and adults for which there is currently no approved treatment," Amryt chief executive, Dr Joe Wiley said in a statement.

Anglo African Oil & Gas PLC (LON:AAOG) said it has noted the recent rise in its share price and confirms that it knows of no reason for this movement. As announced on May 1, 2020, the company has completed the sale of Anglo African Oil & Gas Congo S.A.U to Zenith Energy Limited on the terms set out in the announcement of April 17, 2020.

Silence Therapeutics PLC (LON:SLN), a leader in the discovery, development and delivery of novel RNA therapeutics for the treatment of serious diseases, said its annual general meeting will be held on June 9, 2020, at 10.00am at Herons Ghyll, Tilford Road, Tilford, Surrey GU10 2DD. It added that to comply with the UK Government's Stay at Home measures, shareholders will not be allowed to attend the meeting in person and are strongly encouraged to, therefore, submit their votes, in respect of all matters of business, via proxy as early as possible. If the situation changes then shareholders will be notified via the company's website at https://www.silence-therapeutics.com and via RNS announcement.

Woodbois Limited (LON:WBI),the African focused forestry and timber trading company, has announced that following the release of the audited results for the year ended December 31, 2019, on April 30, the company has made their latest corporate presentation available from the investor centre of the company's website.

Base Resources Limited (LON:BSE) (ASX:BSE), the African mineral sands producer, has announced that the latest investor update presentation is now available from the companys website - http://www.baseresources.com.au - and a pre-recorded webcast of that presentation can be viewed at https://edge.media-server.com/mmc/p/6av8h2ew

Read the original post:
Anglo African Oil & Gas mystified by sharp share price hike - Proactive Investors UK

To Read More: Anglo African Oil & Gas mystified by sharp share price hike – Proactive Investors UK
categoriaSkin Stem Cells commentoComments Off on Anglo African Oil & Gas mystified by sharp share price hike – Proactive Investors UK | dataMay 7th, 2020
Read All

Terminally-ill teen with agonizingly-sensitive skin defies doctors to live to 19 – Metro.co.uk

By daniellenierenberg

Marky Jaquez, 19, has recessive dystrophic epidermolysis bullosa, a condition found in fewer than one in one million newborns. (Picture: Melissa Jaquez/Metro.co.uk)

A teenager whose rare skin disorder means that even the slightest touch leaves him in extreme pain has defied doctors predictions to live to adulthood. Marky Jaquez, from Wichita, Kansas, cannot hug his parents, wear clothes or even walk because any friction causes layers of skin to peel away from his body.

Wheelchair-bound, Marky, 19, has never been able to walk because the ground would shred his feet like a cheese grater and must be covered head-to-toe in bandages to protect his fragile skin from tearing. He has recessive dystrophic epidermolysis bullosa, a condition found in an estimated one in one million newborns that often leads to life-threatening skin infections and even cancer.

The illness is caused by a faulty gene, passed onto children by parents. Tragically, Markys brother Carlos was born with it too, and died aged just 14. Doctors warned Markys parents he was unlikely to live beyond the age of 11, but he defied that grim prediction and will celebrate his 20th birthday later this year.

His mom, Melissa Jaquez, 40, said: Marky only has one layer of skin and because of his genetic makeup, the skin has no way of anchoring itself the body. Any form of touch or friction means his skins just tears away.

Its world shattering to think I will lose both of my boys to this and I dont want to think about what life will be like afterwards. I feel like my purpose in life is to give Mary the best life I can for the time that I have him.

I am not able to hug my son because any friction just causes his skin to come away and tear right off. It causes him excruciating pain and I feel so much guilt, but theres nothing I can do to help him.

But despite all of this he is a very happy and joyful boy and he amazes me every single day. Hes an inspiration and proves to everyone that you can keep going with whatever youre going through, no matter how bad it is.

Marky is the youngest of three brothers born to healthcare worker, Melissa. Eldest son Michael is 24, with Carlos dying of heart failure caused by the skin condition in 2015. Marky and Carlos, who would be 21 this year, were both born with the same condition after inheriting a faulty gene from their parents.

Melissa said doctors suspect both she and the boys father carry the faulty gene that causes the genetic mutation. Although both are unaffected themselves, they have an estimated 25% chance of having a child born with recessive dystrophic epidermolysis bullosa. Melissa has since split up with Marky and Carlos father neither of whom knew they carried the faulty gene until Carlos was born, she said.

Melissa said she became aware of the risks involved with having a child after Carlos was born, but claims she was told by a clinician that the chance of her having a second child with the same condition would be less than 1%.

Melissa said: I lost Carlos to the condition because his heart just gave up. His body was in a constant battle to repair his wounds and that took its toll eventually.

His condition was much more progressive than Markys. He got real bad, real quick and by the end could not even breathe on his own.

My pregnancy with Marky was unplanned, but when I got pregnant I was told the chance of me having another baby with the same condition is 1%. They said having two children with it is unheard of.

Marky was born with the most severe type of epidermolysis bullosa meaning he was delivered without skin on his hands, feet and chest because because of the friction of childbirth.

Ever since Marky was little, Melissa, who is now married to Marcos, 30, has had to spend up to three hours a day covering his skin in protective bandages and cleaning open wounds to prevent infection.

She has said every day of motherhood so far has felt like a battle and admits she has struggled to have a normal mother and son relationship with Marky, because of his condition.

Every day is such a massive challenge for us. I struggle with the grief of knowing that when I walk into my sons room in a morning, we cant have fun. I dont get to do the normal things that a mom and a son does.

Instead when I go into his room I know I have to cause him pain and spend two hours doing his bandages. That does give me a lot of anxiety and guilt.

Taking his bandages off does cause excruciating pain. We have to soak his skin every day to soothe his wounds and give him pain medication. Its incredibly upsetting for me.

Whilst there is no cure for epidermolysis bullosa and Marky is highly likely to sadly one day lose his life to the condition, Melissa is hopefully he will survive for several more years.

He has been selected to take part in experimental treatment to create genetically modified skin stem cells that can slow down the effects of the progressive disease. The family plan to travel to Stamford Hospital, Connecticut, later this year to undergo the treatment.

Melissa and Marcos work opposite shifts and have a carer who comes to help look after Marky for three hours each day. Melissa has paid tribute to her amazing son, who she believes can go on to live for many happy years, despite the predictions of doctors.

She said: The treatment at Stamford could add several years to his life. It will reduce the pain and make it easier for his body to cope.

We have tried for that treatment for years, so were thrilled.

Marky has always been an incredibly happy boy and he has just got on with it, without ever moaning or saying why me. Ive had messages from people all over the world to say Marky has inspired them.

Hes an amazing human being and he makes me so proud.

Go here to read the rest:
Terminally-ill teen with agonizingly-sensitive skin defies doctors to live to 19 - Metro.co.uk

To Read More: Terminally-ill teen with agonizingly-sensitive skin defies doctors to live to 19 – Metro.co.uk
categoriaSkin Stem Cells commentoComments Off on Terminally-ill teen with agonizingly-sensitive skin defies doctors to live to 19 – Metro.co.uk | dataMay 5th, 2020
Read All

Make-up out, skincare in when working from home. Just ask the stars – AsiaOne

By daniellenierenberg

Too lazy to wear make-up while working from home? You're not alone - according to Bloomberg, a recent survey found about 90 per cent of women working remotely during the coronavirus pandemic are going barefaced.

Even celebrities who rarely show themselves without a face full of make-up have joined the fray.

A-listers including Katy Perry, Julia Roberts, Julianne Moore, Salma Hayek, Halle Berry, Helen Mirren and Jessica Alba have all posted make-up-free selfies while stuck at home.

This does not bode well for beauty companies - data from market research firm NPD Group show total beauty sales in the United States declined 58 per cent year on year in the week ending March 28. It can be beneficial, though, if women begin to put their skincare needs first.

"Now that I am home more, I have no excuse to not be good to my skin. New habits include home facials and face rolling. I have also been using my Foreo face massager weekly and I've been thinking about adding in an LED face mask," says Los Angeles-based entrepreneur Tracy Fong.

Fong is not the only one spending more time on her skin. Beauty retailers such as Joyce Beauty may have noted a decline in lipstick sales, but customers are now stocking up on skincare items such as beauty tools and sheet masks.

"I've added steps to my usual, more basic routine and am trying new things," says fashion executive Jane Tong. "I'm enjoying the little bit of 'me time' that I didn't have pre-quarantine. My skin has definitely improved, but I think it can be attributed to giving it more attention, plus more sleep and a slower-paced lifestyle overall."

While staying at home has given women more time to pamper themselves, working from home can bring new skincare concerns. Being stuck indoors all day means that the skin is exposed to a range of new pollutants.

"We all know how damaging the sun's rays can be - but there are many other light wavelengths that we need to be careful of, including blue light. Wherever you live in the world, indoor pollution can be as bad as outdoor pollution. Additional factors such as mould, heating, air conditioning or poor ventilation can stress out the skin," says Nigma Talib, a Los Angeles-based naturopathic doctor and trained medical aesthetician who counts celebrities such as Gwyneth Paltrow and Penelope Cruz among her clients.

For this reason, Talib advocates that women simplify their routines and focus on high-quality products that help counteract environmental aggressors.

At the top of her list is a resurfacing cleanser, which contains exfoliating agents such as glycolic acid and salicylic acid, to help remove dead skin cells which can build up daily.

A nourishing moisturiser packed with ingredients such as collagen and hyaluronic acid can protect against moisture loss and oxidative stress, which occurs when there is an imbalance between free radicals (unstable molecules with the potential to damage cells) and antioxidants in your body.

Don't forget to apply sunscreen, either. "Layer it on top of a serum loaded with plant stem cells. Sunscreen alone won't prevent light damage to the skin, and the addition of plant stem cells makes your sunscreen 10 times more effective," she says.

Forgoing make-up entirely is not necessarily a good thing. Instead, Talib suggests women pare down their routine and choose products that are multipurpose. Invest in "clean" brands free of toxic chemicals and ingredients, and stick to brands that your skin is already familiar with.

"If it's good quality, make-up can sometimes act as a protective barrier to the skin. I like to suggest a no-make-up look that is simple and free from fussy techniques such as contouring." she says.

"Start with a BB cream or tinted moisturiser with SPF that isn't heavy. Go for a natural colour on your lips - either a simple liner or lip gloss - and a coat of mascara to accentuate your eyes.

"Let your natural beauty shine. You might even come out of quarantine more confident in your skin."

For the latest updates on the coronavirus, visithere.

This article was first published in South China Morning Post.

View post:
Make-up out, skincare in when working from home. Just ask the stars - AsiaOne

To Read More: Make-up out, skincare in when working from home. Just ask the stars – AsiaOne
categoriaSkin Stem Cells commentoComments Off on Make-up out, skincare in when working from home. Just ask the stars – AsiaOne | dataMay 5th, 2020
Read All

Stem Cell Treatment for COVID-19; Doctors Divided on Its Scope – The Quint

By daniellenierenberg

A team of doctors and researchers at the Abu Dhabi Stem Cell Center (ADSCC) administered the treatment in the UAE to 73 COVID-19 patients, who were all successfully treated and cured, without any immediate side effects, according to a statement by the United Arab Emirates (UAE) health ministry from 1 May.

The process involved a minimally invasive method where the patients stem cells are extracted, activated and turned into fine mist to be inhaled into the lungs. This was done in addition to the conventional treatment and is expected to work by supporting the established protocol of management of symptoms.

The ministry said in the statement, It is hypothesised to have its therapeutic effect by regenerating lung cells and modulating the immune response to keep it from overreacting to the COVID-19 infection and causing further damage to healthy cells.

The treatment has successfully undergone the initial phase of clinical trials, demonstrating its safety, and further trials for its efficiency are ongoing; expected to be completed in a couple of weeks.

Dr Fatima al-Kaabi, head of haematology and oncology at the Sheikh Khalifa Medical City in the UAE, told CNBC, Its very early to say at this stage. If all went well, this could reach the market in three months, she added.

Going further back, a pilot study in China on seven COVID-19 patients found that intravenous infusions of donor mesenchymal stem cells (MSC) - multipotent stem cells - improved patient outcomes and helped all of them recover. An Israeli pharmaceutical company, Pluristem Therapeutics, also tested stem cells in seven critical hospitalized patients and found positive results.

Additionally, the US Food and Drug Administration (FDA) approved MSC use in extremely sick COVID-19 patients under expanded access compassionate use on 5 April according to a report in The Scientist, even though the experts seemed divided on the logic on which the investigative treatment may have worked.

A hospital in New York tried the therapy as an experiment on 12 patients, 10 of whom were able to come off ventilators, reports CBS news. The Australian regenerative medicine company Mesoblast has also announced a 300-person trial for its stem cell therapy remestemcel-L (which was used in the New York trial) to determine whether it will work on patients suffering with severe lung inflammation.

Currently, there are over 20 active stem cell trials for COVID-19, most focusing on the use of MSCs.

See more here:
Stem Cell Treatment for COVID-19; Doctors Divided on Its Scope - The Quint

To Read More: Stem Cell Treatment for COVID-19; Doctors Divided on Its Scope – The Quint
categoriaSkin Stem Cells commentoComments Off on Stem Cell Treatment for COVID-19; Doctors Divided on Its Scope – The Quint | dataMay 5th, 2020
Read All

Plant Stem Cell Market 2026 Growth Trends by Manufacturers, Regions, Type and Application, Forecast – Latest Herald

By daniellenierenberg

The global Plant Stem Cell Market research report thoroughly explains each and every aspect related to the Plant Stem Cell Market, which facilitates the reports reader to study and evaluate the upcoming market trend and execute the analytical data to promote the business. The growth trend forecasted on account of thorough examination offers in-depth information regarding the global Plant Stem Cell Market. A pathway of development is offered by the market to the several connected networks of businesses under it, which include different firms, industries, organizations, vendors, distributors, and local manufacturers too. All the key Plant Stem Cell Market players compete with each other by offering better products and services at a reasonable price in order to grab significant share at the regional and global level market.

Plant stem cells are undifferentiated cells within the meristems of plants.Plantstem cellsserve as the origin of plant vitality as they maintain themselves and provide a steady supply ofprecursor cellsto form various tissues and organs in plants. Plant stem cells are characterized by two distinctive properties namely its ability to create differentiated celltypes and to self-renew such that the number of stem cells remain stable. The plant stem cell market focuses on this ability of plant cells and thus, processed extracts from the buds, roots and shoots are in high demand and are widely used for topical uses.ription

Get a Sample Copy of this Report: https://www.coherentmarketinsights.com/insight/request-sample/98

The report incorporates an estimated impact of strict standards and regulations set by the government over the market in the upcoming years. The market report also comprises exhaustive research done using several analytical tools such as SWOT analysis to identify the market growth pattern.

Top Manufacturers in GlobalPlant Stem CellMarket Includes:Oriflame Holding AG, MyChelle Dermaceuticals, LLC, Natura Therapeutics Inc, Aidan Products LLC, Mibelle Biochemistry, Phyto Science SDN BHD, and Renature Skin Care Inc.

Regions & Countries Mentioned In The Plant Stem Cell Market Report:

North America ( United States)

Europe ( Germany, France, UK)

Asia-Pacific ( China, Japan, India)

Latin America ( Brazil)

The Middle East & Africa

Key Highlights of the Table of Contents:

Plant Stem Cell Market Study Coverage: It includes key manufacturers covered, key market segments, the scope of products offered in the global market, years considered, and study objectives. Furthermore, it tuches the segmentation study provided in the report on the basis of the type of product and applications.

Plant Stem Cell Market Executive Summary: This section emphasizes on the key studies, market growth rate,Competitive landscape, market drivers, trends, and issues.

Plant Stem Cell Market Production by Region: The report provides information related to import and export, production, revenue, and key players of all regional markets studied are covered in this section.

Plant Stem Cell Market Profile of Manufacturers: Analysis of each market player profiled is detailed in this section. This also provides SWOT analysis, products, production, value, capacity, and other vital factors of the individual player.

Buy This Complete A Business Report: https://www.coherentmarketinsights.com/insight/buy-now/98

Table of Contents

Report Overview:It includes the Plant Stem Cell market study scope, players covered, key market segments, market analysis by application, market analysis by type, and other chapters that give an overview of the research study.

Executive Summary:This section of the report gives information about Plant Stem Cell market trends and shares, market size analysis by region and analysis of global market size. Under market size analysis by region, analysis of market share and growth rate by region is provided.

Profiles of International Players:Here, key players of the Plant Stem Cell market are studied on the basis of gross margin, price, revenue, corporate sales, and production. This section gives a business overview of the players and shares their important company details.

Regional Study:All of the regions and countries analyzed in the Plant Stem Cell market report is studied on the basis of market size by application, the market size by product, key players, and market forecast.

An Overview of the Impact of COVID-19 on this Market:

The pandemic of COVID-19 continues to expand and impact over 175 countries and territories. Although the outbreak appears to have slowed in China, COVID-19 has impacted globally. The pandemic could affect three main aspects of the global economy: production, supply chain, and firms and financial markets. National governments have announced largely uncoordinated, country-specific responses to the virus. As authorities encourage social distancing and consumers stay indoors, several businesses are hit. However, coherent, coordinated, and credible policy responses are expected to offer the best chance at limiting the economic fallout.

National governments and international bodies are focused on adopting collaborative efforts to encourage financial institutions to meet the financial needs of customers and members affected by the coronavirus. However, there are some sectors that have remained unscathed from the impact of the pandemic and there are some that are hit the hardest.

We, at Coherent Market Insights, understand the economic impact on various sectors and markets. Using our holistic market research methodology, we are focused on aiding your business sustain and grow during COVID-19 pandemics. With deep expertise across various industries-no matter how large or small- and with a team of highly experienced and dedicated analysts, Coherent Market Insights will offer you an impact analysis of coronavirus outbreak across industries to help you prepare for the future.

Access insightful study with over 100+ pages, list of tables & figures, profiling 10+ companies https://www.coherentmarketinsights.com/insight/request-pdf/98

About CMI:

Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.

Contact Us:Coherent Market Insights 1001 4th Ave,#3200 Seattle, WA 98154,U.SPhone: US +12067016702 / UK +4402081334027Email: [emailprotected]

More here:
Plant Stem Cell Market 2026 Growth Trends by Manufacturers, Regions, Type and Application, Forecast - Latest Herald

To Read More: Plant Stem Cell Market 2026 Growth Trends by Manufacturers, Regions, Type and Application, Forecast – Latest Herald
categoriaSkin Stem Cells commentoComments Off on Plant Stem Cell Market 2026 Growth Trends by Manufacturers, Regions, Type and Application, Forecast – Latest Herald | dataMay 5th, 2020
Read All

This Low-Maintenance Skincare Routine Will Leave Your Skin Feeling Fresh And Hydrated – Cosmopolitan Philippines

By daniellenierenberg

You might feel pressured to follow a 10-step skincare routine to have the complexion of your dreams. But FYI, a fuss-free routine can be just as effectiveespecially if your goal is as simple as looking and feeling fresh and hydrated. After all, hydration is the key to having a soft, smooth, and clear face. And if you're worried about future fine lines and wrinkles, then you definitely need to use moisturizing products. If youre still not sure about how to build a simple routine, check out our 3-step one below.

Cleansing your skin in the morning can freshen you up for a new day, and at night can remove dirt and grime and prepare you for bed. When choosing a facial wash, look for one that doesnt strip your skin of its natural oils. That way, your skin stays hydrated and wont overproduce oils, which can lead to shine and breakouts.

In the morning, use a gentle cleanser like Cetaphils Gentle Foaming Cleanser. It can remove dirt and oil while moisturizing the skin with vitamins B5 and E. It also has a hypoallergenic, fragrance-free formula, making it great for those with sensitive skin.

At night, use an exfoliating cleanser to get rid of the grime, sweat, and makeup from the day. Try Cetaphils Daily Exfoliating Cleanser, which can gently slough off dead skin cells and clean dirt and oil away without stripping or irritating your skin. It contains bamboo stem extract exfoliant and moisturizing ingredients like Vitamin B5 and E to help your skin feel soft, smooth, and radiant.

While you may only be in your 20s, that doesnt mean you dont have to apply eye cream. Doing so will not only help prevent wrinkles from forming in the future, but will also help address problems you might be dealing with now (hello, dark circles!). Try Cetaphils Hydrating Eye Cream-Serum with Hyaluronic Acid, a cream-serum hybrid that absorbs quickly and moisturizes deeply. Its formulated with hyaluronic acid, a moisturizing agent that can help improve the skins natural elasticity, hold on to moisture in the skin, and improve the appearance of fine lines and fatigue. Those all-nighters youve been pulling dont stand a chance against this product.

Using a creamy moisturizer might sound counterintuitive to feeling fresh, but hear us out! Sometimes, lightweight moisturizers arent enough to keep your skin hydrated all day and all night. Using a cream can help retain your skins natural moisture and protect it from dryness (perfect if youre struggling with dry patches!).

For this, why not try Cetaphils Rich Night Cream? It can help rehydrate and soothe skin, plus, it contains vitamins C, A, and E, plant extracts, and hyaluronic acid to help protect your skin from dryness. BTW, you can even use it during the day if you want! Just lightly apply it on areas that need a little extra TLC.

Shop Cetaphils face range on Lazada and learn more by following Cetaphil on Facebook.

Shop the items in this story!

Originally posted here:
This Low-Maintenance Skincare Routine Will Leave Your Skin Feeling Fresh And Hydrated - Cosmopolitan Philippines

To Read More: This Low-Maintenance Skincare Routine Will Leave Your Skin Feeling Fresh And Hydrated – Cosmopolitan Philippines
categoriaSkin Stem Cells commentoComments Off on This Low-Maintenance Skincare Routine Will Leave Your Skin Feeling Fresh And Hydrated – Cosmopolitan Philippines | dataMay 5th, 2020
Read All

Heres Why You Should Never Skip Eye Cream, According To Dermatologists – Forbes

By daniellenierenberg

Getty

"Do you really need an eye cream?" It's a question that has intrigued many myself includedever since the tiny pots and tubes hit Sephora shelves.

One might wonder why you need a separate cream for your eye area when you already have a moisturizer for the face. Besides, your bathroom cabinet is probably already too crowded without having to add any more products, right?

In an attempt to resolve this skincare dilemma, three dermatologists weigh in on whether eye creams are actually a necessary skincare component or merely a nice-to-have:

Why you should invest in an eye cream?

"The skin around the eyes is thinner and shows signs of aging more quickly than other areas of the face do. This thinness makes it more delicate, vulnerable and prone to allergic reactions than other facial skin," says Dr. Craig Kraffert, board-certified dermatologist and president of Amarte Skin Care.

This is why the delicate skin around your eyes needs an extra dose of TLC, which a regular face moisturizer might not be able to deliver.

Moreover, the skin around your eyes also gets a much greater workout. "Every time you move your eyes, whether you squint, smile or widen them in surprise, you're using muscles around your eyes," notes Dr. Kraffert. Over time, factors like dryness and loss of collagen and elasticity lead to the formation of small wrinkles near your eyes, commonly known as 'crow's feet'. "Smoking and exposure to the sun's harmful ultraviolet rays can also contribute to wrinkle formation," adds the dermatologist.

Incorporating an eye cream into your daily skincare routine can help minimize the appearance of these wrinkles as well as tackle other skin concerns like dryness, puffiness, dark circles and pigmentation, tells Dr. Amy Ross, board-certified dermatologist and advisor for MONATs scientific advisory board.

And the sooner you start using one, the better. "The best time to start using an eye cream is before you think you need one," tells Dr. Ross. "Its easier to prevent signs of aging than correct them, so I recommend investing in an eye cream starting in your 20s," she says. Dr. Kraffert recommends applying an eye cream twice every day for optimal results.

What ingredients should you look for in an eye cream?

"Some key ingredients to look for are caffeine, hyaluronic acid and peptides," says Dr. Ross. Caffeine helps shrink under-eye bags by constricting the blood vessels and reducing inflammation. While peptides boost collagen production, making your skin plumper and more youthful.

Since the skin around your eyes has very few active oil glands, hydrating ingredients like hyaluronic acid, squalane and ceramides are essential for drawing in and sealing in the moisture.

For anti-aging benefits, "choose an eye cream contains retinol or a retinol derivative in a moisturizing baselook for ceramides, dimethicone, glycerin and oils in the ingredient list," says Dr. Estee Williams, a board-certified dermatologist and assistant clinical professor in dermatology at Mount Sinai Medical Center.

In addition, you should also consider factors like your skin type, what skin concern you wish to target, whether you'll be layering makeup on top, etc. when picking an eye cream, suggests Dr. Williams.

The best eye creams for every skin concern:

Whether you want to tackle fine lines, treat dark circles or reduce puffiness, these skincare picks have got you covered:

For dryness: Neutrogena Hydro Boost Gel-Cream

Neutrogena Hydro Boost Gel-Cream

Formulated with ultra-moisturizing hyaluronic acid, Neutrogenas Hydro Boost Gel-Cream penetrates quickly into the skin, plumping the skin cells with long-lasting moisture, making the delicate eye area visibly smooth and supple. It's lightweight, fragrance-free formula makes it suitable for all skin types, including oily and sensitive skin.

For dark circles: Sisley Paris Black Rose Eye Contour Fluid

Sisley Paris Black Rose Eye Contour Fluid

Infused with black rose extract, shea oil and caffeine, this luxe eye cream visibly smooths, revitalizes and brightens the skin around your eyes, making your peepers appear fresh and well-rested.

For de-puffing: Sunday Riley Auto Correct Brightening and Depuffing Eye Contour Cream

Sunday Riley Auto Correct Brightening and Depuffing Eye Contour Cream

Sunday Riley's Auto Correct Brightening and Depuffing Eye Contour Cream features a powerful blend of Brazilian ginseng root extract and caffeine that instantly invigorates and firms up the delicate eye area, reducing the appearance of under-eye bags. In addition, it contains horse chestnut extract that helps improve skin tone and smooth out fine lines.

For fighting photo-damage: Colorescience Total Eye 3-in-1 Renewal Therapy SPF 35

Colorescience Total Eye 3-in-1 Renewal Therapy SPF 35

The skin around your eyes is more sensitive and vulnerable to sun damage than the rest of your facial skin. This is why investing in an eye cream that also provides broad-spectrum protection is a good idea. Colorescience's three-in-one eye cream not only shields the eye area from harmful UVA and UVB rays but also noticeably improves the appearance of dark circles, wrinkles and fine lines.

For firming: No7 Lift & Luminate Triple Action Eye Cream

No7 Lift & Luminate Triple Action Eye Cream

Made with skin-nourishing ingredients like shea butter, ginseng root extract and white mulberry leaf extract, No7s Lift & Luminate Triple Action Eye Cream combats both uneven skin tone and fine lines, leaving your skin noticeably smooth, firm and radiant.

For dull, dry skin: Saturday Skin Wide Awake Brightening Eye Cream

Saturday Skin Wide Awake Brightening Eye Cream

Packed with date seed extract, peptides and avocado protein extract, this ultra-hydrating cream is like a tall glass of water for your skin. Its antioxidant-rich formula nourishes and brightens the delicate eye areamaking it instantly refreshed and reinvigorated.

For wrinkle repair: La Roche-Posay Redermic R Eyes Retinol Eye Cream

La Roche-Posay Redermic R Eyes Retinol Eye Cream

Featuring a potent formula supercharged with pure retinol, caffeine and thermal spring water, La Roche Posay's antioxidant-packed eye cream is a perfect pick for those whose primary skincare concern is wrinkles or fine lines.

For tackling signs of aging: Monat Eye Smooth Nourishing Eye Cream

Monat Eye Smooth Nourishing Eye Cream

Monat Eye Smooth Nourishing Eye Cream

From smoothing out wrinkles and fine lines to diminishing the appearance of dark circles, this rejuvenating cream does it all. Formulated with antioxidant-rich caffeine, peptides and plant stem cells, it plumps, brightens and evens skin tone, revealing a visibly smoother and youthful look around the eyes. Plus, it comes with a compact rose gold eye-roller that helps soothe puffy, stressed-out skin and improve circulation.

Excerpt from:
Heres Why You Should Never Skip Eye Cream, According To Dermatologists - Forbes

To Read More: Heres Why You Should Never Skip Eye Cream, According To Dermatologists – Forbes
categoriaSkin Stem Cells commentoComments Off on Heres Why You Should Never Skip Eye Cream, According To Dermatologists – Forbes | dataMay 4th, 2020
Read All

Schizophrenia drug combined with radiation shows promise in treating deadly brain tumours, says study – Free Press Journal

By daniellenierenberg

Washington: A recent study has suggested that adding a drug once commonly used to treat schizophrenia to traditional radiation therapy helped improve overall survival in mice with glioblastoma, one of the deadliest and most difficult-to-treat brain tumours.

The findings of the study conducted by researchers at the UCLA Jonsson Comprehensive Cancer Center and colleagues was published in the journal 'Proceedings of the National Academy of Sciences'.

It shows that a combination of radiation and the drug trifluoperazine not only targets glioblastoma cells but also helps overcome the resistance to treatment so common to this aggressive form of cancer. The results could prove promising for patients with the disease, for whom the median survival time is only 12 to 18 months following diagnosis.

Radiation is an integral part of therapy for people with cancer and one of the most effective treatments. In many cases, it can help cure the disease. But in glioblastoma, tumour cells often become resistant to radiation treatment because the radiation itself can induce "phenotype conversion," a process that turns certain non-tumour stem cells into tumour-producing cells, causing cancer to reoccur.

"While radiotherapy is one of the few treatments that prolong survival in glioblastoma patients, radiation alone does very little in treating the disease in our models because we are dealing with highly aggressive tumours," said the study's senior author, Dr Frank Pajonk, a professor of radiation oncology at the David Geffen School of Medicine at UCLA and a member of the Jonsson Cancer Center.

"The drug trifluoperazine by itself does not do much either, but we found when you combine them, they become highly efficient. Importantly, the drug does not sensitise cells to radiation but rather prevents the occurrence of resistant glioma stem cells," Pajonk added.

UCLA researchers have been exploring new ways to prevent glioblastoma tumour cells from becoming resistant to radiation by adding drugs to the treatment regimen that have traditionally been used for other purposes.

To find out if there were any existing drugs that could interfere with the radiation-induced phenotype conversion, the team screened more than 83,000 compounds through the shared resources at UCLA, which provides researchers access to specialised equipment and services to help them pursue cutting-edge research.

They were able to identify nearly 300 compounds, including the dopamine receptor antagonist trifluoperazine, that had the potential to block phenotype conversion and improve the efficacy of radiation therapy.

Once trifluoperazine was identified, it was tested on mice with patient-derived orthotopic tumours. The team found that when used in combination with radiation, trifluoperazine successfully delayed the growth of the tumours and significantly prolonged the overall survival of the animals.

Combining radiation treatment with trifluoperazine extended survival in 100 per cent of the mice to more than 200 days, compared to 67.7 days in the control group receiving only radiation.

"Many preclinical glioblastoma studies report fairly small increases in overall survival in mice, and that rarely translates into benefits for patients," said Pajonk, who is also a member of the Eli and Edythe Broad Center of Regenerative Medicine and Stem Cell Research at UCLA.

"But here, we see pretty drastic effects in improved overall survival and I find that very encouraging. It gives us hope that this is all going to translate into a benefit for people," Pajonk further said.

The team plans to start a clinical trial this summer for people with recurrent glioblastoma to test using dopamine receptor antagonist with radiation therapy.

"I think we can find a combination of treatments with radiation that is very tolerable to patients and can do well," said co-author Leia Nghiemphu, an associate professor of clinical neurology at the Geffen School of Medicine and principal investigator on the upcoming clinical trial. "The next step is to see if we can stop this resistance to radiation in humans," added Nghiemphu.

Go here to read the rest:
Schizophrenia drug combined with radiation shows promise in treating deadly brain tumours, says study - Free Press Journal

To Read More: Schizophrenia drug combined with radiation shows promise in treating deadly brain tumours, says study – Free Press Journal
categoriaSkin Stem Cells commentoComments Off on Schizophrenia drug combined with radiation shows promise in treating deadly brain tumours, says study – Free Press Journal | dataMay 3rd, 2020
Read All

Increasing Demand for Cytokines Market to Substantially Surge the Revenues Through the COVID-19 Lockdown Phase and Forecast 2019 2029 Cole Reports -…

By daniellenierenberg

Cytokines are the cell signaling molecules which are secreted from the different body cells. Cytokines are the proteins which play an important role of messenger between cells and regulates various physiological and metabolic activities. Cytokines regulate various inflammatory responses, stimulate blood cells production, and stimulate tissue development & maintenance. Cytokine is a large family of the small protein which includes tumors necrosis factor, interleukins, interferons, lymphokines and chemokines. Cytokines are produced by a wide range of cells includes cells like macrophages, lymphocytes, T lymphocytes, endothelial cells, mast cells, fibroblasts, stromal cells and cells. Some cytokines developed into protein therapeutics to treat bone-related disorders, anemia, cancer, infection, multiple sclerosis. Cytokine is most commonly used in the research & development activities in the field of life sciences and drug development.

Request to Sample report @ https://www.persistencemarketresearch.com/samples/30223

Increasing research and development activities expected to favour the growth of the cytokines market. As well as growing life science research funding boost up the growth of the cytokines market. Increasing prevalence of diseases such as cancer and skin disorders expected to drive the growth of the cytokines market. The growing demand for regenerative medicines impels the growth of the cytokines market. The growing demand for cytokines for wound management and cancer therapeutics expected to drive the growth of the market. Growing funding for cancer-based research influencing the growth of cytokines market. Growing cell culture-based research activities and increasing demand for cytokines in stem cell biology are major factors expected to drive the growth of the cytokines market. Growing manufacturers investments in cell culture media production expected to favour the growth of the growth factors market over the forecast period. Growing strategic acquisition and merger activities among market players is the major trend in the cytokines market. The high cost of research-based cytokines products is the major factor expected to restrain the growth of the cytokines market.

Request PMR insights on measuring the impact of COVID-19 coronavirus across industries.

The global cytokines market is segmented on basis of product type, application, end users and region:

Cytokine is the large family of cytokines includes tumour necrosis factor-TNF, interleukins (IL), interferons, chemokines and other cytokines. Interleukins (IL) is the most commonly used cytokine and have large family. IL-1 family, IL-4 family, IL-6 family, IL-10 family are mostly commonly used interleukins family in the research. Cytokines are used in various field of the research such as dermatology, cancer, orthopedics, respiratory and other fields. Cytokines are used for the research application among end users such as pharmaceutical & biotechnology companies, contract research organizations and academic & research institutes.

North America expected to dominate the global cytokines market as increasing demand for cytokines products as increasing research and development activities. Europe expected to contribute second-highest revenue share in global cytokines market as a growing number of clinical trial and drug development activities. The Asia Pacific expected to grow with the highest growth rate in the cytokines market as an increasing number of pharmaceutical manufacturers, biotechnology companies and academic institutions in the Asia Pacific region. India, South Korea & China cytokines market expected to grow with a higher growth rate as growing research and development funding from the government. The Middle East & Africa cytokines market expected to grow with the lowest growth rate due to lack of research and development activities in the region.

Request to View TOC @ https://www.persistencemarketresearch.com/toc/30223

Some of the players operating in the global cytokines market are ,

For in-depth competitive analysis, buy [emailprotected] https://www.persistencemarketresearch.com/checkout/30223

See the rest here:
Increasing Demand for Cytokines Market to Substantially Surge the Revenues Through the COVID-19 Lockdown Phase and Forecast 2019 2029 Cole Reports -...

To Read More: Increasing Demand for Cytokines Market to Substantially Surge the Revenues Through the COVID-19 Lockdown Phase and Forecast 2019 2029 Cole Reports -…
categoriaSkin Stem Cells commentoComments Off on Increasing Demand for Cytokines Market to Substantially Surge the Revenues Through the COVID-19 Lockdown Phase and Forecast 2019 2029 Cole Reports -… | dataMay 2nd, 2020
Read All

Best Skin Care Routine: Order of Products to Use Morning & Night – Glamour

By daniellenierenberg

Now that your makeup layer is gone, you can proceed with washing your face. "A cleanser gets rid of dead skin, pollutants, oils, dirt, and bacteria," says Rabach. Both she and Ciraldo recommend also doing this step when you first wake up in the morning, in order to prep your skin to absorb the active ingredients in your other products.

The best cleanser for you will depend on your skin type. "It's important to pay attention to what's in your cleanser and what's not in it," says Ciraldo. She recommends avoiding sulfates, which can have a harsh, stripping effect on your faceand looking for actives that suit your needs. "For normal or dry skin, I favor a hydrating cleanser with peptides," she says. "If you're oily or acne-prone, use a mild exfoliating cleanser with salicylic acid, which dislodges the dead cells that can clog pores."

Do This Step: Morning and Night

The first product to go on your face? Eye cream. The reason is simplebecause you'll probably forget to do it otherwise. Ciraldo recommends patting eye cream on gently with your ring finger (this way you'll tug less at the delicate skin there) all the way around your eyes, not just underneath them. If you're worried about eye cream causing your concealer or eye makeup to smear, choose a more lightweight option, like a hydrating gel that sinks in quickly and stays put.

For the best results, look for ingredients like peptideswhich help tighten your skin and de-puffas well as antioxidants. Rabach recommends formulas that contain hydrating hyaluronic acid, brightening caffeine, and ceramides (these lock in moisture and help strengthen your skin barrier).

Do This Step: Morning and Night

Both toners and essences are meant to help further prime your skin to absorb active ingredients, but the one you choose will depend on your skin type. Old-school toners were meant to balance skin pH and counteract alkaline soaps, before soap-free cleansers became popular. Now, toner usually refers to liquid formulations geared toward oily skin that's in need of gentle exfoliation and resurfacing. Ciraldo says those with oily or acne-prone skin should look for toners with ingredients like glycolic or salicylic acid.

Essences, on the other hand, tend to be more hydrating. Rabach recommends looking for actives like hyaluronic acid, which will flood your skin with moisture that you can lock in during subsequent steps. To apply, soak a cotton pad in liquid and gently pat it over your face. Alternatively, you can use your hands to do the same thing.

Do This Step: Morning and Night

This is the step where you'll deliver the bulk of active ingredients to your toner/essence-primed face, and it's important to do it early on in your routine. "Serums are formulated with smaller molecular-weight actives so they penetrate into deeper skin layers," says Ciraldo. "If you apply your serum after a thicker formulation, the active ingredients may not penetrate as well."

While you should apply serum twice a day, you shouldn't be using the same formulation. "Serum actives differ for day and night," says Rabach. During the day, she likes to choose serums with antioxidants that protect skin from daytime stressors like free radicals (caused by UV rays), pollutants, and blue light. The most popular ingredient for this is vitamin C, which you will have no problem finding in serum form. (Just make sure to choose one that's properly stabilized for maximum effect.) At night, opt for a serum with peptides and growth factors to repair skin.

For both daytime and nighttime serums, Rabach also has a general list of ingredients she likes to look for across both formulations: Niacinamide to reduce redness, hyaluronic acid to pull moisture into your skin, and alpha and beta hydroxy acids (AHAs and BHAs), which help boost collagen and even out skin pigmentation. Ciraldo further splits up her preferred serum ingredients by skin type. "For acne-prone skin, look for stem cells, retinol, and green tea," she says. "For dehydrated skin, look for lipids, hyaluronic acid, and peptides. And for hyperpigmented skin, look for vitamin C."

Do This Step: At Night Only

Read more from the original source:
Best Skin Care Routine: Order of Products to Use Morning & Night - Glamour

To Read More: Best Skin Care Routine: Order of Products to Use Morning & Night – Glamour
categoriaSkin Stem Cells commentoComments Off on Best Skin Care Routine: Order of Products to Use Morning & Night – Glamour | dataMay 1st, 2020
Read All

Induced Pluripotent Stem Cells Market to Witness CAGR 8.7% Growth in Revenue During the Period 2026 – Cole of Duty

By daniellenierenberg

The healthcare industry has been focusing on excessive research and development in the last couple of decades to ensure that the need to address issues related to the availability of drugs and treatments for certain chronic diseases is effectively met. Healthcare researchers and scientists at the Li Ka Shing Faculty of Medicine of the Hong Kong University have successfully demonstrated the utilization of human induced pluripotent stem cells or hiPSCs from the skin cells of the patient for testing therapeutic drugs.

The success of this research suggests that scientists have crossed one more hurdle towards using stem cells in precision medicine for the treatment of patients suffering from sporadic hereditary diseases. iPSCs are the new generation approach towards the prevention and treatment of diseases that takes into account patients on an individual basis considering their genetic makeup, lifestyle, and environment. Along with the capacity to transform into different body cell types and same genetic composition of the donors, hiPSCs have surfaced as a promising cell source to screen and test drugs.

Report Highlights:

Get Sample Copy of Report @ https://www.persistencemarketresearch.com/samples/17968

Company Profile

Get To Know Methodology of Report @ https://www.persistencemarketresearch.com/methodology/17968

In the present research, hiPSC was synthesized from patients suffering from a rare form of hereditary cardiomyopathy owing to the mutations in Lamin A/C related cardiomyopathy in their distinct families. The affected individuals suffer from sudden death, stroke, and heart failure at a very young age. As on date, there is no exact treatment available for this condition.

This team in Hong Kong tested a drug named PTC124 to suppress specific genetic mutations in other genetic diseases into the iPSC transformed heart muscle cells. While this technology is being considered as a breakthrough in clinical stem cell research, the team at Hong Kong University is collaborating with drug companies regarding its clinical application.

The unique properties of iPS cells provides extensive potential to several biopharmaceutical applications. iPSCs are also used in toxicology testing, high throughput, disease modeling, and target identification. This type of stem cell has the potential to transform drug discovery by offering physiologically relevant cells for tool discovery, compound identification, and target validation.

A new report by Persistence Market Research (PMR) states that the globalinduced pluripotent stem or iPS cell marketis expected to witness a strong CAGR of 7.0% from 2018 to 2026. In 2017, the market was worth US$ 1,254.0 Mn and is expected to reach US$ 2,299.5 Mn by the end of the forecast period in 2026.

Access Full Report @ https://www.persistencemarketresearch.com/checkout/17968

Customization to be the Key Focus of Market Players

Due to the evolving needs of the research community, the demand for specialized cell lines have increased to a certain point where most vendors offering these products cannot depend solely on sales from catalog products. The quality of the products and lead time can determine the choices while requesting custom solutions at the same time. Companies usually focus on establishing a strong distribution network for enabling products to reach customers from the manufacturing units in a short time period.

Entry of Multiple Small Players to be Witnessed in the Coming Years

Several leading players have their presence in the global market; however, many specialized products and services are provided by small and regional vendors. By targeting their marketing strategies towards research institutes and small biotechnology companies, these new players have swiftly established their presence in the market.

Link:
Induced Pluripotent Stem Cells Market to Witness CAGR 8.7% Growth in Revenue During the Period 2026 - Cole of Duty

To Read More: Induced Pluripotent Stem Cells Market to Witness CAGR 8.7% Growth in Revenue During the Period 2026 – Cole of Duty
categoriaSkin Stem Cells commentoComments Off on Induced Pluripotent Stem Cells Market to Witness CAGR 8.7% Growth in Revenue During the Period 2026 – Cole of Duty | dataApril 30th, 2020
Read All

Amniotic Membrane Market: Locally Available Amniotic Allografts Increasingly Meeting Needs of Patients with Joint Pain – BioSpace

By daniellenierenberg

Transparency Market Research (TMR)has published a new report on theamniotic membrane marketfor the forecast period of2019-2027. According to the report, the global amniotic membrane market was valued at ~US$ 980 Mnin2018and is projected to expand at a CAGR of ~10%from2019to2027.

GlobalAmniotic Membrane Market:Overview

Request for Brochure of Report - https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=42059

Increase in Research on Stem Cell Biology & Regenerative Medicineto Drive Market

Cryopreserved Amniotic Membrane Products to Dominate Market

Request for Analysis of the COVID19 Impact on Amniotic Membrane Market - https://www.transparencymarketresearch.com/sample/sample.php?flag=covid19&rep_id=42059

Ophthalmology to be Promising Application

Hospitals Account for Major Share of Global Market

North America to Dominate Global Amniotic Membrane Market

Request for Custom Research - https://www.transparencymarketresearch.com/sample/sample.php?flag=CR&rep_id=42059

Global Amniotic Membrane Market: Competitive Landscape

About Us

Transparency Market Research is a next-generation market intelligence provider, offering fact-based solutions to business leaders, consultants, and strategy professionals.

Our reports are single-point solutions for businesses to grow, evolve, and mature. Our real-time data collection methods along with ability to track more than one million high growth niche products are aligned with your aims. The detailed and proprietary statistical models used by our analysts offer insights for making right decision in the shortest span of time. For organizations that require specific but comprehensive information we offer customized solutions through ad hoc reports. These requests are delivered with the perfect combination of right sense of fact-oriented problem solving methodologies and leveraging existing data repositories.

TMR believes that unison of solutions for clients-specific problems with right methodology of research is the key to help enterprises reach right decision.

Contact

Transparency Market ResearchState Tower,90 State Street,Suite 700Albany NY - 12207United StatesUSA - Canada Toll Free: 866-552-3453Email:sales@transparencymarketresearch.comWebsite:https://www.transparencymarketresearch.com

Originally posted here:
Amniotic Membrane Market: Locally Available Amniotic Allografts Increasingly Meeting Needs of Patients with Joint Pain - BioSpace

To Read More: Amniotic Membrane Market: Locally Available Amniotic Allografts Increasingly Meeting Needs of Patients with Joint Pain – BioSpace
categoriaSkin Stem Cells commentoComments Off on Amniotic Membrane Market: Locally Available Amniotic Allografts Increasingly Meeting Needs of Patients with Joint Pain – BioSpace | dataApril 30th, 2020
Read All

23 Best Korean Beauty Products, According to Koreans Hair, Makeup, Skin-Care Reviews – Allure Magazine

By daniellenierenberg

Although I live in New York City, many of my friends call Seoul, South Korea, home. Through our many FaceTimes, KakaoTalk messages, and visits, they've introduced me to trendy Korean beauty brands that haven't made their way to America yet, like Hince, Sioris, and Nonfiction. They also share their picks from K-beauty brands we know and love in the U.S., such as Sulwhasoo, Dr. Jart, and Nature Republic. Every time I hear about their favorite products, I'm fascinated by how different they are from our stateside K-beauty offerings.

We're only exposed to a fraction of what is available on the other side of the world, and we are missing out on dreamy lip tints, barely-there cushion foundations, and magical moisturizers. With this in mind, I put my friends' makeup, hair, and skin-care selections in one place.

Some background on the names I'm about to mention: Daniella is my clean beauty expert. Whenever I see her, she always gives me a bag full of goodies made with natural, cruelty-free ingredients. When I want to know about the hottest brands at the moment, I go to Haylie. Joyce, founder of consulting agency Talk to Her, always has her eye out for the latest K-beauty innovations. Tattoo artist Young, on the other hand, mixes classic imports, like SK-II and Urban Decay, with unexpected K-beauty finds.

Consider this a list of K-beauty products Koreans actually use.

All products featured on Allure are independently selected by our editors. However, when you buy something through our retail links, we may earn an affiliate commission.

See the rest here:
23 Best Korean Beauty Products, According to Koreans Hair, Makeup, Skin-Care Reviews - Allure Magazine

To Read More: 23 Best Korean Beauty Products, According to Koreans Hair, Makeup, Skin-Care Reviews – Allure Magazine
categoriaSkin Stem Cells commentoComments Off on 23 Best Korean Beauty Products, According to Koreans Hair, Makeup, Skin-Care Reviews – Allure Magazine | dataApril 28th, 2020
Read All

Clariant taps natural sponges and apple trees for new beauty ingredients – Cosmetics Business

By daniellenierenberg

By Sarah Parsons 28-Apr-2020

Hair Care | Ingredients | Skin Care

The Swiss-led speciality chemicals manufacturer Clariant Active Ingredients has developed two new plant-based ingredients

Speciality chemicals giant Clariant has unveiled its latest beauty ingredients.

This week, the Swiss-led company launched two new plant-based ingredients for skin and hair.

Clariant Active Ingredients, Clariant's beauty business unit, released Rootness Energize, an extract of Luffa cylindrica, otherwise known as Egyptian cucumber, and can also be used as a natural cleaning sponge.

Developed for the skin, Claraint claims that sustainably-sourced Rootness Energize is rich in bryonolic acid, and can increase energy production in skin cells and stimulate ATP production.

"In turn, Rootness Energize visibly increases skin elasticity and reduces age-related lack of tonicity and firmness appealing factors for products such as firming creams, skin elasticity boosters and revitalising care products for well-aging skin care," explained the company.

Reported visible results include more than a 20% increase in firmness, tonicity and elasticity with 1% Rootness Energize.

For the hair, Clariant Active Ingredients has developed EquiScalp to target tightness, extreme dryness, itchiness and redness.

Based on stem cells from the Central Asian Malus domestica apple tree, according to the firm, the ingredient protects the scalp as it maintains the level of healthy bacteria.

Malus domestica is said to contain concentrated phloridzin, which can control inflammation as well as sebum overproduction.

Clariant Active Ingredients recommends EquiScalp for oily scalp treatments, sensitive scalp formulas and scalp itch erasers.

Alexandre Lapeyre, Global Head of Marketing, Clariant Active Ingredients, described EquiScalp and Rootness Energize as examples of using technology to develop sustainable ingredients.

"We apply science to nature to create potent actives effective at addressing very specific beauty needs, each one underpinned by plant resources preservation, traceability, no exploitation of cultural land and ecological cultivation," Lapeyre said.

"In doing so, we help cosmetic formulators support consumers requests for scientifically-proven and sustainably-sourced plant derived ingredients.

Like this story? For the latest in ingredients, formulation, packaging and regulation subscribe to SPC Magazine, for more information click here.

The rest is here:
Clariant taps natural sponges and apple trees for new beauty ingredients - Cosmetics Business

To Read More: Clariant taps natural sponges and apple trees for new beauty ingredients – Cosmetics Business
categoriaSkin Stem Cells commentoComments Off on Clariant taps natural sponges and apple trees for new beauty ingredients – Cosmetics Business | dataApril 28th, 2020
Read All

‘A key pillar of the future’: Givaudan tips growth for ingredients developed with green biotech – CosmeticsDesign-Asia.com

By daniellenierenberg

Mathais Fleury, Givaudans global category manager of biotech actives, told CosmeticsDesign-Asia that leveraging on green biotechnology would allow companies to find solutions to consumers desire for products that are natural, sustainable and high-performing.

Green Biotech truly is a key pillar of the future. Consumers are looking for more naturality while protecting nature a difficult challenge, made possible by biotech along with a high level of innovation, said Fleury.

Most recently, the Swiss company collaborated with South Korean biotech company BIO-FD&C to tackle two frustrating beauty concerns by leveraging on green biotechnology.

It recently unveiled two actives, K-phyto [SC] Camellia and K-phyto [PP] GHK, which were developed to address dry scalp and oily skin respectively.

This exclusive partnership with Bio FD&C leverages the untapped power of plants through stem cell cultures and unique phytopeptides. It allows our experts to offer innovative natural and reliable solutions for hair and skin care issues such as dry scalp and oily skin, while protecting our planet, said Fleury.

K-phyto [SC] Camellia is an ingredient obtained from camellia phytoplacenta cells culture.

According to the company, the active can increase the scalp moisture content by 13.8%. This reinforces the epidermal cohesion of the scalp keratinocytes and reduces dry flakes and dandruff down by 33.6%.

It also was observed soothe the scalp by being able to reduce erythema down 6.6%.

According to Givaudan, having botanical claims with popular ingredients such as camellia, more commonly known as Tsubaki in the region, can drive hair care product launches by 70% in APAC.

The second ingredient, K-phyto [PP] GHK, is a molecule that combines botanicals and peptides to act on the mechanisms of sebum production.

Clinical studies have shown facial sebum production reduction by 35.5% in two weeks and 67.5% in one month.

Oily skin is a major claim requested by the market, specifically in APAC. Clinical results with the phytopeptide we've chosen to bring to market are outstanding and we definitely believe this could be a game changer, said Fluery.

The Swiss firm believes that the two actives showed a lot of promise for the global market.

Our partner was already doing a very good job in its local market, but we want to leverage our access to different places over the world to highlight its expertise and know-how. This collaboration is a real opportunity to bring innovative ingredients to consumers globally, and that's why we'll offer these products to our partners all over the world, said Fleury.

Additionally, these ingredients are aligned with the ideals of clean beauty, one of the most talked-about trends in the beauty market right now.

The two technologies that we've identified in Bio FD&C portfolio are a perfect answer to this need of clean beauty combined with performance, said Fluery.

More here:
'A key pillar of the future': Givaudan tips growth for ingredients developed with green biotech - CosmeticsDesign-Asia.com

To Read More: ‘A key pillar of the future’: Givaudan tips growth for ingredients developed with green biotech – CosmeticsDesign-Asia.com
categoriaSkin Stem Cells commentoComments Off on ‘A key pillar of the future’: Givaudan tips growth for ingredients developed with green biotech – CosmeticsDesign-Asia.com | dataApril 28th, 2020
Read All

Page 20«..10..19202122..3040..»